UK DRI at Cardiff
At the UK DRI at Cardiff, we're exploring the function of genes involved in Alzheimer’s, Parkinson’s and Huntington’s disease. We will use this knowledge to identify new molecular targets that can lead us to discover new drugs to prevent or treat dementia.
Contact
Hadyn Ellis Building, Maindy Road, Cardiff, CF24 4HQ
Tina Cottrell
The UK DRI at Cardiff is the biggest investment Wales has made in neurodegenerative disease research to date. The Centre brings together scientists from a range of research backgrounds, with expertise in genetics, immunology, computational analytics, synaptic function and DNA repair.
The highly collaborative team bring fresh ideas and perspectives, and are working together to discover new disease mechanisms, identify drug targets, and ultimately deliver new treatments for Alzheimer’s, Parkinson’s, Huntington’s and other neurodegenerative diseases.
Vacancy: Centre Director, UK DRI at Cardiff
The UK Dementia Research Institute (UK DRI), principally funded by the Medical Research Council (MRC), and Cardiff University are seeking to appoint an outstanding established academic to a new Chair in Neuroscience and to leadership of the UK DRI Centre at Cardiff within the School of Medicine. The internationally recognised scientist can work in any area relevant to the Institute's overarching mission, including the biology of behavioural and psychiatric features of dementia.
Closing date: 20 March 2025
Full information
Latest news
People
Scientific focus
Read about the scientific focus of the UK DRI at Cardiff
